Stocks · Coverage Archive

$ARGX

980.00 ▲ 15.12%

Every Regards of Wallstreet article on $ARGX, newest first — 1 story and counting.

Followed tickers pin their next report date and latest coverage to the homepage and the earnings calendar.

  1. 2026-08-17 · 7 min read

    Why Is Argenx (ARGX) Stock Up Today? A Myositis Trial With No Rival Drug

    Argenx shares jumped roughly 11% in premarket trading Monday after its ALKIVIA Phase 3 trial hit its primary endpoint, a 15.4-point gain over placebo in autoimmune myositis.

New to options? See our plain-English strategy playbook →

The Week-Ahead Brief

Don’t miss next week’s setups. Get the Saturday brief.

Every Saturday: next week’s earnings dates, Fed days and the trades worth watching, from the same desk that writes the week-ahead hub. Free, built for retail investors.

Subscribing means we email you the newsletter and nothing else. No spam, no sharing your address, unsubscribe in one click. See the privacy policy.